These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Procedure guideline for thyroid scintigraphy (version 3)]. Dietlein M, Dressler J, Eschner W, Leisner B, Reiners C, Schicha H, Deutsche Gesellschaft für Nuklearmedizin, Deutsche Gesellschaft für Medizinische Physik. Nuklearmedizin; 2007 Oct; 46(5):203-5. PubMed ID: 17938755 [Abstract] [Full Text] [Related]
3. Nuclear Imaging in Pediatric Kidney Diseases. Dhull RS, Joshi A, Saha A. Indian Pediatr; 2018 Jul 15; 55(7):591-597. PubMed ID: 30129542 [Abstract] [Full Text] [Related]
4. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation. O'Malley JP, Ziessman HA, Chantarapitak N. Clin Nucl Med; 1993 Jan 15; 18(1):22-9. PubMed ID: 8422715 [Abstract] [Full Text] [Related]
5. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function. Taylor A, Ziffer JA, Eshima D. Clin Nucl Med; 1990 Jun 15; 15(6):371-8. PubMed ID: 2141307 [Abstract] [Full Text] [Related]
6. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction. Aktaş A, Aras M, Colak T, Gençoğlu A, Karakayali H. Transplant Proc; 2006 Mar 15; 38(2):449-53. PubMed ID: 16549144 [Abstract] [Full Text] [Related]
7. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography. Mustafa S, Elgazzar AH. J Nucl Med; 2013 May 15; 54(5):801-6. PubMed ID: 23528384 [Abstract] [Full Text] [Related]
12. Separate calculation of glomerular and tubular clearance by means of renal scintigraphy with hippuran and DTPA. Hadj Aissa A, Collard M, Pozet N, Zech P, Traeger J. Nephron; 1985 May 15; 40(4):401-4. PubMed ID: 3895005 [Abstract] [Full Text] [Related]
13. Effects of radiofrequency ablation on individual renal function: assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy. Mukai T, Sato S, Iguchi T, Mimura H, Yasui K, Gobara H, Saika T, Nasu Y, Kumon H, Kanazawa S. Acta Med Okayama; 2006 Apr 15; 60(2):85-91. PubMed ID: 16680184 [Abstract] [Full Text] [Related]
14. Investigation of the relation between administered dose and image quality for pediatric 99mTc-DMSA renal scintigraphy: clinical study applying the JSNM (Japanese Society of Nuclear Medicine) pediatric dosage card : The Japanese Society of Nuclear Medicine Technology (JSNMT), the Optimization of Imaging Technique Committee for Pediatric Nuclear Medicine Studies. Fujiwara T, Hidaka K, Sugibayashi K, Matsumoto M, Kida T, Shiina K. Ann Nucl Med; 2019 Mar 15; 33(3):153-159. PubMed ID: 30484259 [Abstract] [Full Text] [Related]
15. An incidental detection of aortic aneurysm on Tc-99m MAG3 renal scintigraphy. Sadic M, Demirel K, Koca G, Atilgan HI, Korkmaz M. Nucl Med Rev Cent East Eur; 2013 Mar 15; 16(2):97-9. PubMed ID: 24068642 [Abstract] [Full Text] [Related]
16. Superiority of tc-99m MAG3 to tc-99m DTPA in treating a patient with mild renal artery stenosis. Kiratli PO, Caner B, Altun B, Cekirge S. Ann Nucl Med; 2001 Feb 15; 15(1):45-8. PubMed ID: 11355781 [Abstract] [Full Text] [Related]
17. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note. Fraile M, Castell J, Buxeda M, Cuartero A, Cantarell C, Domenech-Torné FM. Eur J Nucl Med; 1989 Feb 15; 15(12):776-9. PubMed ID: 2533892 [Abstract] [Full Text] [Related]
18. [Follow-up after kidney transplantation. Sequential functional scintigraphy with technetium-99m-DTPA or technetium-99m-MAG3]. Kramer W, Baum RP, Scheuermann E, Hör G, Jonas D. Urologe A; 1993 Mar 15; 32(2):115-20. PubMed ID: 8475609 [Abstract] [Full Text] [Related]
19. Technetium-99m-N,N-ethylenedicysteine and Tc-99m DMSA scintigraphy in the evaluation of renal parenchymal abnormalities in children. Kibar M, Yapar Z, Noyan A, Anarat A. Ann Nucl Med; 2003 May 15; 17(3):219-25. PubMed ID: 12846544 [Abstract] [Full Text] [Related]